3/4
08:00 am
ewtx
Edgewise Therapeutics to Present at the Leerink Global Healthcare Conference on March 11, 2026
Low
Report
Edgewise Therapeutics to Present at the Leerink Global Healthcare Conference on March 11, 2026
3/3
08:13 am
ewtx
Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2026 MDA Clinical and Scientific Conference [Yahoo! Finance]
Low
Report
Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2026 MDA Clinical and Scientific Conference [Yahoo! Finance]
3/3
08:00 am
ewtx
Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2026 MDA Clinical and Scientific Conference
Low
Report
Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2026 MDA Clinical and Scientific Conference
3/2
09:30 am
ewtx
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
Low
Report
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
2/28
05:57 am
ewtx
Edgewise Therapeutics (EWTX) was upgraded by HC Wainwright to "strong-buy".
Low
Report
Edgewise Therapeutics (EWTX) was upgraded by HC Wainwright to "strong-buy".
2/28
01:30 am
ewtx
Low
Report
2/26
05:03 pm
ewtx
Edgewise Therapeutics (EWTX) had its "outperform" rating reaffirmed by Evercore Inc.
Low
Report
Edgewise Therapeutics (EWTX) had its "outperform" rating reaffirmed by Evercore Inc.
2/26
12:11 pm
ewtx
Edgewise Therapeutics (EWTX) was given a new $25.00 price target by Stifel Nicolaus.
Low
Report
Edgewise Therapeutics (EWTX) was given a new $25.00 price target by Stifel Nicolaus.
2/26
08:35 am
ewtx
Assessing Edgewise Therapeutics (EWTX) Valuation After Strong Multi-Year Returns And Recent Share Price Momentum [Yahoo! Finance]
Low
Report
Assessing Edgewise Therapeutics (EWTX) Valuation After Strong Multi-Year Returns And Recent Share Price Momentum [Yahoo! Finance]
2/26
08:19 am
ewtx
Edgewise Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results with Strong Progress Across Muscular Dystrophy and Cardiovascular Programs [Yahoo! Finance]
Low
Report
Edgewise Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results with Strong Progress Across Muscular Dystrophy and Cardiovascular Programs [Yahoo! Finance]
2/26
08:00 am
ewtx
Edgewise Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results with Strong Progress Across Muscular Dystrophy and Cardiovascular Programs
Low
Report
Edgewise Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results with Strong Progress Across Muscular Dystrophy and Cardiovascular Programs
2/15
01:09 am
ewtx
Edgewise Therapeutics (NASDAQ:EWTX) was upgraded by analysts at
Wall Str
Low
Report
Edgewise Therapeutics (NASDAQ:EWTX) was upgraded by analysts at
Wall Str
2/9
10:58 am
ewtx
Edgewise Therapeutics (NASDAQ:EWTX) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Medium
Report
Edgewise Therapeutics (NASDAQ:EWTX) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
2/7
02:07 am
ewtx
Edgewise Therapeutics (NASDAQ:EWTX) was downgraded by analysts at
Wall S
Medium
Report
Edgewise Therapeutics (NASDAQ:EWTX) was downgraded by analysts at
Wall S
2/5
08:15 am
ewtx
Edgewise Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 12, 2026 [Yahoo! Finance]
Medium
Report
Edgewise Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 12, 2026 [Yahoo! Finance]
2/5
08:00 am
ewtx
Edgewise Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 12, 2026
Medium
Report
Edgewise Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 12, 2026
2/2
08:00 am
ewtx
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
Low
Report
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
1/24
12:30 am
ewtx
Edgewise Therapeutics (NASDAQ:EWTX) was upgraded by analysts at
Wall Str
Low
Report
Edgewise Therapeutics (NASDAQ:EWTX) was upgraded by analysts at
Wall Str
1/14
03:36 am
ewtx
A Look At Edgewise Therapeutics (EWTX) Valuation After J P Morgan Clinical Pipeline Update [Yahoo! Finance]
High
Report
A Look At Edgewise Therapeutics (EWTX) Valuation After J P Morgan Clinical Pipeline Update [Yahoo! Finance]
1/13
08:00 am
ewtx
Edgewise Therapeutics Provides Corporate Updates and Highlights Priorities for 2026
Low
Report
Edgewise Therapeutics Provides Corporate Updates and Highlights Priorities for 2026
1/6
08:00 am
ewtx
Edgewise Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026
Low
Report
Edgewise Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026
1/5
08:00 am
ewtx
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
Low
Report
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
12/29
06:02 pm
ewtx
This Biotech Fund Exited an $8 Million Edgewise Stake as the Stock Slid Double Digits [Yahoo! Finance]
Low
Report
This Biotech Fund Exited an $8 Million Edgewise Stake as the Stock Slid Double Digits [Yahoo! Finance]
12/29
02:57 pm
ewtx
Edgewise: Maintaining Buy On Part D EDG-7500 Data And Next Q2 2026 Catalyst [Seeking Alpha]
Low
Report
Edgewise: Maintaining Buy On Part D EDG-7500 Data And Next Q2 2026 Catalyst [Seeking Alpha]
12/27
01:05 am
ewtx
Edgewise Therapeutics (NASDAQ:EWTX) was downgraded by analysts at
Wall S
Medium
Report
Edgewise Therapeutics (NASDAQ:EWTX) was downgraded by analysts at
Wall S